ASHP to FDA: Serial NDCs Present Numerous Problems
4/13/2009
A proposal by the Food and Drug Administration (FDA) to use a serialized National Drug Code (NDC) to secure the drug supply would not help in the adoption of bar-code medication administration and may be vulnerable to drug counterfeiters, ASHP told the agency this week. ASHP also reiterated the need for the FDA to begin exploring the development of a more effective alternative to the NDC.
FDA is developing a standardized numerical identifier that would be applied to medication packages by manufacturers or repackagers.
Click here to read ASHP’s letter.
Read More
|